Aclaris Therapeutics, Inc. (ACRS)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 1 signal for Aclaris Therapeutics, Inc.. Most notable: 2026-08-06: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement
  2. Large insider sale
    Leonard Braden Michael (ten_percent_owner) sold $1.4M of stock

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-08-01Kolbeck Roland WilhelmofficerM36,375
2026-08-01Kolbeck Roland WilhelmofficerF12,3855.2$64,402
2026-06-05SCHIFF ANDREW NdirectorM11,580
2026-06-05Molineaux Christopher P.directorM11,580
2026-06-05MILANO VINCENTdirectorM11,580
2026-06-05Mehra AnanddirectorM11,580
2026-06-05Humphries William D.directorM11,580
2026-06-05GOWEN MAXINEdirectorM11,580
2026-06-05Mehra AnanddirectorM11,580
2026-06-05SCHIFF ANDREW NdirectorM11,580
2026-06-05Humphries William D.directorM11,580
2026-06-05Molineaux Christopher P.directorM11,580
2026-06-05MILANO VINCENTdirectorM11,580
2026-06-05GOWEN MAXINEdirectorM11,580
2026-05-01Hall Jesse WayneofficerM36,375
2026-05-01Hall Jesse WayneofficerF9,3304.41$41,145
2026-05-01Hall Jesse WayneofficerM36,375
2026-05-01Hall Jesse WayneofficerF9,3304.41$41,145
2026-04-23Leonard Braden Michaelten percent ownerS300,0004.53$1,359,000
2026-04-23Leonard Braden Michaelten percent ownerS300,0004.53$1,359,000
2026-03-01Balthaser KevinofficerF6772.87$1,943
2026-03-01Balthaser KevinofficerM2,375
2026-03-01Balthaser KevinofficerM2,375
2026-03-01Balthaser KevinofficerF6772.87$1,943
2026-02-03Loerop JamesofficerM20,875
2026-02-03Loerop JamesofficerF5,9373.47$20,601
2026-02-03Walker NealdirectorM63,475
2026-02-03Walker NealdirectorF18,6113.47$64,580
2026-02-03Davis Hugh M.directorM18,675
2026-02-03Balthaser KevinofficerM22,025
2026-02-03Balthaser KevinofficerF6,4493.47$22,378
2026-02-03Loerop JamesofficerM20,875
2026-02-03Loerop JamesofficerF5,9373.47$20,601
2026-02-03Walker NealdirectorM63,475
2026-02-03Walker NealdirectorF18,6113.47$64,580
2026-02-03Davis Hugh M.directorM18,675
2026-02-03Balthaser KevinofficerM22,025
2026-02-03Balthaser KevinofficerF6,4493.47$22,378
2026-02-01Loerop JamesofficerM7,500
2026-02-01Loerop JamesofficerF10,6863.51$37,508
2026-02-01Loerop JamesofficerM11,250
2026-02-01Loerop JamesofficerM14,750
2026-02-01Balthaser KevinofficerF4,9843.51$17,494
2026-02-01Balthaser KevinofficerM14,750
2026-02-01Loerop JamesofficerM11,250
2026-02-01Loerop JamesofficerM7,500
2026-02-01Loerop JamesofficerM14,750
2026-02-01Loerop JamesofficerF10,6863.51$37,508
2026-02-01Balthaser KevinofficerM14,750
2026-02-01Balthaser KevinofficerF4,9843.51$17,494

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings